-
The Escalator: Argenx, Gilead Sciences, Bristol Myers Squibb and more
08 Jan 2026 13:42 GMT
… appointed Al Gianchetti as CEO.
ElevateBio named Christopher … Murphy as CEO, succeeding interim CEO Ger Brophy, … appointed CEO of Alloy Genetic Medicines.
Gilead Sciences promoted Keeley … directors.
Departures:
Argenx CEO Tim Van Hauwermeiren will …
-
GSK’s oncology and HIV drugs drive 7% sales rise in 2025
04 Feb 2026 19:33 GMT
… ) as the company’s new CEO, Luke Miels, takes the helm … call on 4 February, the CEO of GSK-owned ViiV Healthcare … 2025, Citi analysts expect that Gilead Sciences will continue to be the … to 2026 and beyond, new CEO Luke Miels hopes to guide …
-
People moves: Gilead Sciences welcomes new EVP, general counsel, legal and compliance
29 Dec 2025 19:26 GMT
… their legal teams
Nasdaq-listed Gilead Sciences has named Keeley Wettan … and report to chairman and CEO Daniel O’Day.
Wettan … , Parsons’ chair, president and CEO.
Martinez enters the role having … says Paul Raymond, president and CEO at Alithya.
Elsewhere, Jim …
-
Gilead Sciences to acquire Repare’s RP-3467
26 Dec 2025 09:46 GMT
Gilead Sciences has signed an agreement to … arrangement transaction.
Repare Therapeutics president, CEO and chief financial officer Steve …
-
Flagship CEO Calls Out Attacks on Science, Warns of China Dominance
12 Jan 2026 10:32 GMT
… “human-made miracles,” Flagship Pioneering CEO Noubar Afeyan wrote in his … , devastating diseases.”
The dignitary referenced Gilead Sciences’ twice-yearly HIV injection lenacapavir …
-
Gilead Sciences Appoints Keeley Wettan as EVP, General Counsel, Legal & Compliance
18 Dec 2025 14:54 GMT
Gilead Sciences Inc. has appointed Keeley Wettan … Daniel O’Day, Chairman and CEO, Gilead Sciences. “During her 14-year career …
-
Mirum doubles down on diversified rare disease strategy
04 Feb 2026 04:33 GMT
… get acquired,” said Chris Peetz, CEO of Mirum Pharmaceuticals. “Because a … , Sanofi gobbled up Blueprint Medicines, Gilead Sciences snapped up CymaBay Therapeutics, and …
-
3T Biosciences Announces Appointments of Behzad Kharabi, M.D., as Chief Medical Officer, and Parker Institute for Cancer Immunotherapy (PICI) CEO Karen Knudsen, MBA, Ph.D., to Board of Directors
06 Jan 2026 14:18 GMT
… D., chief executive officer (CEO) of the Parker Institute … Pharmaceuticals, Kite Pharmaceuticals/Gilead Sciences, and T-Knife Therapeutics. … , San Francisco.
PICI CEO Joins Board of Directors
… She previously served as CEO of the American Cancer …
-
LOLA YOUNG TO PERFORM AT 34TH ANNUAL ELTON JOHN AIDS FOUNDATION ACADEMY AWARDS® VIEWING PARTY
03 Feb 2026 21:24 GMT
… A+E Global Media, Chopard, Gilead Sciences, Robert and Dana Kraft, Bob … AIDS," said Anne Aslett, CEO, Elton John AIDS Foundation. …
-
Lola Young to Perform at Elton John AIDS Foundation Oscar Party
03 Feb 2026 14:52 GMT
… A+E Global Media, Chopard, Gilead Sciences, Robert and Dana Kraft, Bob … tools to end AIDS,” EJAF CEO Anne Aslett said. “We fund …